Citation Impact
Citing Papers
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
2011 Standout
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function
2009
Breast cancer
2019 Standout
The gut hormone glucagon-like peptide-1 produced in brain: is this physiologically relevant?
2013
Human Milk Composition
2012 Standout
GLP‐1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells
2003
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
2016
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*
2003 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in Adult Patients with Severe Liver Disease before and after Orthotopic Liver Transplantation
2002
Enhanced survival and mucosal repair after dextran sodium sulfate–induced colitis in transgenic mice that overexpress growth hormone
2001
Effects of GLP-1-(7–36)NH2, GLP-1-(7–37), and GLP-1- (9–36)NH2on Intravenous Glucose Tolerance and Glucose-Induced Insulin Secretion in Healthy Humans
2003
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Alcohol and Breast Cancer
2001
Exendin‐4 differentiation of a human pancreatic duct cell line into endocrine cells: Involvement of PDX‐1 and HNF3β transcription factors
2002
The glucagon-like peptide-1 metabolite GLP-1-(9–36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans
2006
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
2003
Necroptosis in the Pathophysiology of Disease
2019
Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B
2005
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
The biology of incretin hormones
2006 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Multimodal strategies to improve surgical outcome
2002 Standout
Effect of the Lycium barbarum polysaccharides on age-related oxidative stress in aged mice
2006 Standout
Growth Factors in Inflammatory Bowel Disease
1999
Differential Gene Expression in the Rat Skeletal and Heart Muscle in Glucocorticoid-Induced Myopathy: Analysis by Microarray
2003
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
2014 Standout
Irritable bowel syndrome
2016 Standout
Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats
2008
Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats
1998
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
1998
TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by β-Catenin and Glycogen Synthase Kinase-3β
2004
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
2002
Is Milk-Borne Insulin-Like Growth Factor-I Essential for Neonatal Development?
1997
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
2003
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Biology of Incretins: GLP-1 and GIP
2007 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Glucagon-like peptide 1(GLP-1) in biology and pathology
2005
Intestinal mucosal barrier function in health and disease
2009 Standout
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
2003
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
Functional gastrointestinal disorders and mast cells: implications for therapy
2005
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
2011
Insulin-Like Growth Factor-I (IGF-I) Attenuates Jejunal Atrophy in Association with Increased Expression of IGF-I Binding Protein-5 in Parenterally Fed Mice1
2005
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
2002
The Physiology of Glucagon-like Peptide 1
2007 Standout
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
The hormone resistin links obesity to diabetes
2001 StandoutNature
Enterotrophic Effect of Insulin‐Like Growth Factor‐I but not Growth Hormone and Localized Expression of Insulin‐Like Growth Factor‐I, Insulin‐Like Growth Factor Binding Protein‐3 and ‐5 mRNAs in Jejunum of Parenterally Fed Rats
2000
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus
2003
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
2009 Standout
Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Gαs and Gαi/Gαo activation
2001
The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice
1999
Efficacy of nutritional pharmacology in surgical patients
1998
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
Autoreceptor Control of Peptide/Neurotransmitter Corelease from PDF Neurons Determines Allocation of Circadian Activity in Drosophila
2012 StandoutNobel
Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitro
2000
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Cardiac excitation–contraction coupling
2002 StandoutNature
Regulation of gene expression by insulin
1991
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness
2002
Dietary Conjugated Linoleic Acids Alter Serum IGF-I and IGF Binding Protein Concentrations and Reduce Bone Formation in Rats Fed (n-6) or (n-3) Fatty Acids
1999
Glucagon-like Peptide-1: The Basis of a New Class of Treatment for Type 2 Diabetes
2004
A family of tissue-specific resistin-like molecules
2001
The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases
2008 Standout
Protein Kinase Cζ Activation Mediates Glucagon-Like Peptide-1–Induced Pancreatic β-Cell Proliferation
2001
Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
1999
The Role of CNS Glucagon-Like Peptide-1 (7-36) Amide Receptors in Mediating the Visceral Illness Effects of Lithium Chloride
2000
Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease
2014
Pathogenesis of Diabetic Neuropathy
1998
Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes
2001
Effects of Aging on Immune Function
2011
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
2004 Standout
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
2000
Glucose-Dependent Insulinotropic Polypeptide Promotes β-(INS-1) Cell Survival via Cyclic Adenosine Monophosphate-Mediated Caspase-3 Inhibition and Regulation of p38 Mitogen-Activated Protein Kinase
2003
Secretion, Degradation, and Elimination of Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide in Patients with Chronic Renal Insufficiency and Healthy Control Subjects
2004
Effect of Enteral IGF‐1 Supplementation on Feeding Tolerance, Growth, and Gut Permeability in Enterally Fed Premature Neonates
2008
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7–36) Amide or Exendin-(9–39) Alters Body Weight in the Rat**This work was supported by the United Kingdom Medical Research Council.
1999
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Insulinotropic Hormone Glucagon-Like Peptide-1 Differentiation of Human Pancreatic Islet-Derived Progenitor Cells into Insulin-Producing Cells
2002
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
2003
Glucose-dependent Insulinotropic Polypeptide Activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway
2002
The Glucagon-Like Peptides
1999
Regulation of Components of the Ubiquitin System by Insulin-Like Growth Factor I and Growth Hormone in Skeletal Muscle of Rats Made Catabolic with Dexamethasone
1999
Microglial M1/M2 polarization and metabolic states
2015 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Asymmetric Enamine Catalysis
2007 StandoutNobel
Glucagon-Like Peptide-1 Inhibits Apoptosis of Insulin-Secreting Cells via a Cyclic 5′-Adenosine Monophosphate-Dependent Protein Kinase A- and a Phosphatidylinositol 3-Kinase-Dependent Pathway
2003
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
DAMPs, PAMPs and alarmins: all we need to know about danger
2006 Standout
GLP-1-(9–36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion
2002
GLP-1(7-36)-amide and Exendin-4 Stimulate the HPA Axis in Rodents and Humans
2010
Works of Huan Yang being referenced
Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models
2019
Ethanol-Fed Sprague-Dawley Rats Maintain Normal Levels of Insulin-like Growth Factor I ,
1992
Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes
1997
Serum insulin-like growth factors and their binding proteins in patients with hepatic failure and after liver transplantation
1998
High Potency Antagonists of the Pancreatic Glucagon-like Peptide-1 Receptor
1997
Insulin‐Like Growth Factor‐I Enhances Immune Response in Dexamethasone‐Treated or Surgically Stressed Rats Maintained With Total Parenteral Nutrition
1995
Insulin‐Like Growth Factor‐I but Not Growth Hormone Attenuates Dexamethasone‐Induced Catabolism in Parenterally Fed Rats
1996
Effects of streptozotocin-induced diabetes mellitus on growth and hepatic insulin-like growth factor I gene expression in the rat
1990
Stimulation of Intestinal Growth Is Associated with Increased Insulin-Like Growth Factor-Binding Protein 5 mRNA in the Jejunal Mucosa of Insulin-like Growth Factor-I-Treated Parenterally Fed Rats
1997
Pancreatic Glucagon-Like Peptide-1 Receptor Couples to Multiple G Proteins and Activates Mitogen-Activated Protein Kinase Pathways in Chinese Hamster Ovary Cells*
1999
Anabolic effect of IGF-I coinfused with total parenteral nutrition in dexamethasone-treated rats
1994
GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor
1998
High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRNA and alters serum levels of insulin-like growth factor—Binding protein-1, -3, -5, and -6 in the rat
1995